2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular …
S Halvorsen, J Mehilli, S Cassese, TS Hall… - European heart …, 2022 - academic.oup.com
Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …
evidence shows that it can be considered medically appropriate to a given condition and if …
Tricuspid regurgitation
RT Hahn - New England Journal of Medicine, 2023 - Mass Medical Soc
Tricuspid Regurgitation | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …
AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …
that, unless otherwise provided for by national regulations, offlabel use of medication should …
Transcatheter repair for patients with tricuspid regurgitation
P Sorajja, B Whisenant, N Hamid, H Naik… - … England Journal of …, 2023 - Mass Medical Soc
Background Severe tricuspid regurgitation is a debilitating condition that is associated with
substantial morbidity and often with poor quality of life. Decreasing tricuspid regurgitation …
substantial morbidity and often with poor quality of life. Decreasing tricuspid regurgitation …
Transcatheter aortic-valve replacement in low-risk patients at five years
MJ Mack, MB Leon, VH Thourani… - … England Journal of …, 2023 - Mass Medical Soc
Background A previous analysis in this trial showed that among patients with severe,
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology …
V Delgado, N Ajmone Marsan, S de Waha… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[HTML][HTML] Transcatheter treatment for tricuspid valve disease: Transcatheter treatment for tricuspid valve disease
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …
Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper
P Lancellotti, P Pibarot, J Chambers… - European Heart …, 2022 - academic.oup.com
Valvular regurgitation represents an important cause of cardiovascular morbidity and
mortality. Imaging is pivotal in the evaluation of native valve regurgitation and …
mortality. Imaging is pivotal in the evaluation of native valve regurgitation and …